Jane Street »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Jane Street

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Jane Street from 13F filings

Historical chart of Jane Street investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Jane Street consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Jane Street

Quarter filed Position value Share count Share price at filing
2025-09-30 $912k 550k 1.66
2025-03-31 $3.1M 2.7M 1.15
2023-12-31 $9.0M 9.4M 0.95
2023-09-30 $6.8M 7.3M 0.93

More positions owned by Jane Street

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Spdr Gold Tr Gold Shs (GLD)
Apple Call Option (AAPL)
Taiwan Semiconductor Mfg Sponsored Ads Put Option (TSM)
Microsoft Corporation Call Option (MSFT)
Advanced Micro Devices Call Option (AMD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Strategy Cl A New (MSTR)
Broadcom Call Option (AVGO)
Amazon Call Option (AMZN)

View all positions for Jane Street

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ing Investment Management
Bnp Paribas Arbitrage, Snc
State Street Corporation
Manufacturers Life Insurance Company
FMR
MacKay Shields
LMR Partners
Parallax Volatility Advisers
Morgan Stanley
BlackRock
Lord, Abbett & Co
Universal- Beteiligungs- und Servicegesellschaft mbH
SSI Investment Management
Jpmorgan Chase & Co
Nicholas Investments Partners

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1